The GCC repeat length in the 5′UTR of MRP1 gene is polymorphic: A functional characterization of its relevance for cystic fibrosis

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Nicolis, Elena ^a   Pasetto, Matteo ^a   Cigana, Cristina ^a   Pradal, Ugo ^a   Assael, Baroukh M ^a   Melotti, Paola ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

5' UNTRANSLATED REGION; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA FLANKING REGION; DRUG RESPONSE; ELECTROPHORESIS; GENE FREQUENCY; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; REGULATORY SEQUENCE; REPORTER GENE; RESPIRATORY EPITHELIUM; SAMPLE SIZE; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TRINUCLEOTIDE REPEAT;

5' FLANKING REGION; 5' UNTRANSLATED REGIONS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CYSTIC FIBROSIS; GENE FREQUENCY; GENETICS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMORPHISM, GENETIC; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEATS;

EID: 32944480006     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-7     Document Type: Article

References (25)

1. Lindsell PHJ: Glutathione permeability of CFTR. Am J Physiol 1998, 275:C323.
2. Gao LKK, Yankaskas JR, Forman HJ: Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999, 277:L113.
3. Altschuler EL: Azithromycin, the multidrug-resistant protein, and cystic fibrosis. Lancet 1998, 351:1286.
4. Lallemand JY, Stoven V: Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis? Lancet 1997, 350:711-712.
5. Hurbain I, Sermet-Gaudelus I: Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. Pediatr Res 2003, 54:627-634.
6. Pradal U, Cipolli M, Cazzola G: Chloride transport may be restored by long-term azithromycin treatment in patients with cystic fibrosis. Pediatr Pulmonol 2000:280.
7. Pradal U, Delmarco A: Long term azithromycin in cystic fibrosis: another possible mechanism of action? J Chemother 2005, 17:384-400.
8. Pradal U, Delmarco A: Azithromycin induces over-expression of multidrug resistance-associated protein (MRP) and restores chloride conductance in cystic fibrosis [abstract]. J Cystic Fibrosis 2002, 1:s52.
9. Zhu Q, Center MS: Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 1994, 54:4488-4492.
10. Kruh GD, Gaughan KT: Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 1995, 87:1256-1258.
11. Dean M, Rzhetsky A. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001, 11:1156-1166.
12. Loe DW, Deeley RG: Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996, 32A:945-957.
13. Venkatakrishnan ASA, King G, Blackwell TR, Bringham KL, Christman JW, Blackwell TS: Exaggerated activation of NF-kB and altered 1kB-beta processing in cystic fibrosis bronchial epithelial cells. American Journal of Respiratory Cell Molecular Biology 2000. 23:396-403.
14. Henrion A, Flamant C, Roussey M, Strange RC, Chadelat K, Clement A: Severity of cystic fibrosis is associated with gene polymorphism of anti-oxidizing enzymes [abstract]. Pediatr Pulmonol 2001, 22:s215.
15. Baranov VS, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, Malet P, Perriot J, Mouraire P, Baskakov VN, Savitskyi GA, Gorbushin S, Deyneka SI, Michnin E, Barchuck A, Vakharlovsky V, Pavlov G, Shilko, VI, Guembitzkaya T, Kovaleva L: Proportion of the GSTM 1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996, 97:516-520.
16. Jirsch JR, Deeley G: Inwardly rectifying K+ channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells. Cancer Res 1993, 53:4156-4160.
17. Hainsworth AH, Henderson RM: Hypotonicity-induced anion fluxes in cells expressing the multidrug-resistance-associated protein, MRP. Pflugers Arch 1996, 432:234-240.
18. Borst P, Kool RE, Wijnholds M: A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000, 92:1295-1302.
19. Leslie EM, Cole SP: Toxicological relevance of the multidrug resistance protein 1, MRP 1 (ABCC 1) and related transporters. Toxicology 2001, 67:3-23.
20. Wijnholds J, van Leudsen MR, Mol CA, Zaman GJ, Mayer U, Beijnen J, der Valk M, Krimpenfort P, Borst P: Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 1997, 3:1275-1279.
21. Miller SA, Dykes DD: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
22. Cipolli M, Novelli G, Cassetta MI, Fallani S, Mazzei T: Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis. Clin Drug Invest 2001, 21:353.
23. Wang Z, Wang B, Tang K, Lee EJD, Chong SS, Lee CGL: A functional polymorphism within the MRP 1 gene locus identified through its genomic signature of positive selection. Hum Mol Gen 2005, 14:2075-2087.
24. Zaldivar F, Nugent DJ: Identification of a novel regulatory element in the human interleukin 1 alpha (1L-1 alpha) gene promoter. Cytokine 2002, 20:130-135.
25. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB: Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res 1994, 54:5607-5613.